Can AI Help Manage Hypertension?
Pennington Biomedical Research Center’s Dr. Yun Shen will lead a team to explore the use of AI for precision hypertension management in Type-2 diabetes care. The research is funded through an award of $250,000 from the Collaboration in Action Program, established by Championship Health Partners LSU and Our Lady of the Lake Health.
Hypertension is a comorbidity present in 85 percent of patients who have Type-2 diabetes, leading to a significant increase in risk of cardiovascular issues. The research project, “Harnessing AI for precision hypertension management: Advancing treatment paradigms in type 2 diabetes care,” will examine a large collection of anonymized data from Our Lady of the Lake Health’s electronic health records for Type 2 diabetes patients.
Researchers will apply this data to an artificial intelligence-based decision-making system, which will help interpret the data and guide personalized drug dosing and treatments. The goal is enhanced blood pressure control, reduced cardiovascular risks, and improved quality of life for patients.
Excerpted from News Medical Life Sciences
